List of works by Ennio Giulio Favalli

A review of the literature analyzing benefits and concerns of infliximab biosimilar CT-P13 for the treatment of rheumatologic diseases: focus on interchangeability.

scientific article

Anti-CarP antibodies as promising marker to measure joint damage and disease activity in patients with rheumatoid arthritis.

scientific article published in February 2015

Anti-TNFalpha therapy in a cohort of rheumatoid arthritis patients: clinical outcomes

scientific article published on 21 November 2008

Are patients with systemic lupus erythematosus at increased risk for COVID-19?

scientific article published on 25 May 2020

Biomarkers in psoriatic arthritis: a systematic literature review

scientific article published on 28 January 2016

Challenges and Advances in Targeting Remission in Axial Spondyloarthritis

scientific article

Change Over Time in the Pattern of Clinical Response to First-line Biologic Drugs in Patients with Rheumatoid Arthritis: Observational Data in a Real-life Setting

scientific article published in February 2017

Clinical evaluation of a novel chemiluminescent immunoassay for the detection of anti-citrullinated peptide antibodies

scientific article published on 30 July 2014

Comments on "Short-term reasons for withdrawal and adverse events associated with apremilast therapy for psoriasis in real-world practice compared with in clinical trials: A multicenter retrospective study"

scientific article published on 07 August 2018

Comparison of efficacy of first- versus second-line adalimumab in patients with rheumatoid arthritis: experience of the Italian biologics registries

scientific article published on 8 May 2017

Considerations for improving quality of care of patients with rheumatoid arthritis and associated comorbidities

scientific article published on 01 July 2020

Does polymorphysm of genes coding for pro-inflammatory mediators predict the clinical response to tnf alpha blocking agents? A review analysis of the literature

scientific article published on 04 February 2011

Drug survival of adalimumab in patients with rheumatoid arthritis over 10 years in the real-world settings: high rate remission together with normal function ability.

scientific article published on 14 July 2016

Drug-induced lupus following treatment with infliximab in rheumatoid arthritis.

scientific article published on January 2002

Effects of anti-TNF alpha drugs on disability in patients with rheumatoid arthritis: long-term real-life data from the Lorhen Registry.

scientific article

Efficacy and safety of anti-tumour necrosis factor in elderly patients with rheumatoid arthritis: an observational study

scientific article published on 01 April 2010

Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register

scientific article

Eight-Year Retention Rate of First-Line Tumor Necrosis Factor Inhibitors in Spondyloarthritis: A Multicenter Retrospective Analysis.

scientific article published on October 2016

Erratum to: Anti-CarP antibodies as promising marker to measure joint damage and disease activity in patients with rheumatoid arthritis

scientific article published on 01 May 2015

Factors Predicting Early Failure of Etanercept in Rheumatoid Arthritis: An Analysis From the Gruppo Italiano di Studio sulla Early Arthritis (Italian Group for the Study of Early Arthritis) Registry

scientific article published on 07 February 2020

Factors influencing the choice of first- and second-line biologic therapy for the treatment of rheumatoid arthritis: real-life data from the Italian LORHEN Registry.

scientific article

How advances in personalized medicine will change rheumatology

scientific article published on 02 February 2018

Impact of corticosteroids and immunosuppressive therapies on symptomatic SARS-CoV-2 infection in a large cohort of patients with chronic inflammatory arthritis

scientific article published on 30 December 2020

Incidence of cancer in patients with spondyloarthritis treated with anti-tnf drugs

scientific article published on 8 September 2017

Increasing the threshold for patient global assessment in defining remission may have a different impact in patients with early and established rheumatoid arthritis

scientific article published on 20 April 2020

Inflammatory and prothrombotic biomarkers in patients with rheumatoid arthritis: Effects of tumor necrosis factor-α blockade

scholarly article by Francesca Ingegnoli et al published September 2008 in Journal of Autoimmunity

International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphos

scientific article

Is there a need for new thresholds to define remission and low disease activity by Disease Activity Score 28 calculated with C reactive protein? Real life data from a local registry

scientific article published on 10 October 2014

Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the GISEA registry

scientific article published on 13 July 2012

Mavrilimumab: a unique insight and update on the current status in the treatment of rheumatoid arthritis

scientific article published on 17 June 2019

Newly Identified Antiatherosclerotic Activity of Methotrexate and Adalimumab: Complementary Effects on Lipoprotein Function and Macrophage Cholesterol Metabolism

scientific article published on 01 May 2015

Novel mechanisms of action of the biologicals in rheumatic diseases.

scientific article published on August 2014

Obesity and reduction of the response rate to anti-tumor necrosis factor α in rheumatoid arthritis: an approach to a personalized medicine

scientific article published in January 2013

Patient preferences in the choice of anti-TNF therapies in rheumatoid arthritis. Results from a questionnaire survey (RIVIERA study)

scientific article published on 17 November 2009

Persistence, switch rates, drug consumption and costs of biological treatment of rheumatoid arthritis: an observational study in Italy

scientific article published on 21 December 2016

Predicting response to anti-TNF treatment in rheumatoid arthritis patients.

scientific article published on 27 January 2009

Predictors of response to anti-TNF therapy in RA patients with moderate or high DAS28 scores

scientific article published on 2 June 2013

Prevalence of Ankylosing Spondylitis Disease Activity Score (ASDAS) inactive disease in a cohort of patients treated with TNF-alpha inhibitors.

scientific article published on 7 September 2017

Profile of sarilumab and its potential in the treatment of rheumatoid arthritis.

scientific article published on 24 May 2017

Real-life 10-year retention rate of first-line anti-TNF drugs for inflammatory arthritides in adult- and juvenile-onset populations: similarities and differences

scientific article published on 8 June 2017

Role of antimalarials in COVID-19: observational data from a cohort of rheumatic patients

scientific article published on 19 June 2020

Sarilumab: patient-reported outcomes in rheumatoid arthritis

scientific article published on 20 August 2018

Serious infections during anti-TNFalpha treatment in rheumatoid arthritis patients.

scientific article

Spotlight on mavrilimumab for the treatment of rheumatoid arthritis: evidence to date

scientific article

Structural integrity versus radiographic progression in rheumatoid arthritis

scientific article

Survival on treatment with second-line biologic therapy: a cohort study comparing cycling and swap strategies

scientific article published on 05 June 2015

Survival on treatment with second-line biologic therapy: a cohort study comparing cycling and swap strategies.

scientific article published on 12 April 2014

Switch or swap strategy in rheumatoid arthritis patients failing TNF inhibitors? Results of a modified Italian Expert Consensus

scholarly article by Monica Todoerti et al published 1 October 2018 in Rheumatology

Switching TNF-alpha antagonists in rheumatoid arthritis: the experience of the LORHEN registry

scientific article published on 31 December 2009

TNF-alpha antagonist survival rate in a cohort of rheumatoid arthritis patients observed under conditions of standard clinical practice

scientific article published on 01 September 2009

Targeting Granulocyte-Monocyte Colony-Stimulating Factor Signaling in Rheumatoid Arthritis: Future Prospects

scientific article published on 01 November 2019

Ten-year drug survival of anti-TNF agents in the treatment of inflammatory arthritides

scientific article published on 01 November 2014

The 12-item Psoriatic Arthritis Impact of Disease Questionnaire: Construct Validity, Reliability, and Interpretability in a Clinical Setting

scientific article published on 01 December 2016

The Use of Rheumatic Disease Comorbidity Index for Predicting Clinical Response and Retention Rate in a Cohort of Rheumatoid Arthritis Patients Receiving Tumor Necrosis Factor Alpha Inhibitors

scientific article published on 10 January 2019

The management of first-line biologic therapy failures in rheumatoid arthritis: Current practice and future perspectives

scientific article published on 13 October 2017

The profiling of axial spondyloarthritis patient candidate to a biologic therapy: Consensus from a Delphi-panel of Italian experts

article

The role of biologic agents in damage progression in rheumatoid arthritis: indirect comparison of data coming from randomized clinical trials

scientific article

The role of concomitant methotrexate dosage and maintenance over time in the therapy of rheumatoid arthritis patients treated with adalimumab or etanercept: retrospective analysis of a local registry.

scientific article published on 24 May 2018

The role of methotrexate as combination therapy with etanercept in rheumatoid arthritis: Retrospective analysis of a local registry.

scientific article published on September 2016

Tocilizumab in the treatment of rheumatoid arthritis: an evidence-based review and patient selection

article

Treatment comparison in rheumatoid arthritis: head-to-head trials and innovative study designs

scientific article published on 16 April 2014

Treatment of rheumatoid arthritis with anti-TNF-alpha agents: a reappraisal

scientific article

Tumour necrosis factor antagonist therapy and cancer development: analysis of the LORHEN registry

scientific article published on 30 July 2009

Twelve-Year Retention Rate of First-Line Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis: Real-Life Data From a Local Registry.

scientific article

Two-year persistence of golimumab as second-line biologic agent in rheumatoid arthritis as compared to other subcutaneous tumor necrosis factor inhibitors: real-life data from the LORHEN registry.

scientific article published on 30 October 2017

Ultrasonography in the diagnosis and management of patients with inflammatory arthritides

scientific article

Understanding the Role of Interleukin-6 (IL-6) in the Joint and Beyond: A Comprehensive Review of IL-6 Inhibition for the Management of Rheumatoid Arthritis

scientific article published on 30 July 2020

What is the true incidence of COVID-19 in patients with rheumatic diseases?

scientific article published on 22 April 2020

Paulina is supported by:

About Paulina

Help